AI-powered histopathology demonstrates predictive value for immunotherapy outcomes in pMMR mCRC, advanced ccRCC, and NSCLC with data featured in both oral and poster presentations SEOUL, South Korea, Oct. 14, 2025 -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced the presentation of three studies at the European Society for Medical Oncology (ESMO) Congress 2025, taking place October 17–21 in Berlin, Germany. All three studies highlight how Lunit's AI pathology solution, Lunit SCOPE IO®, can identify biomarkers that p
Neobank elevates customer value and deepens engagement through Ascenda's global rewards network NEW YORK, Oct. 14, 2025 -- Ascenda, the loyalty company that powers growth for the world's leading financial institutions, today announced its new partnership with bunq, Europe's second-largest neobank. The collaboration elevates bunq's loyalty program, unlocking superior rewards that power its users' international lifestyle. bunq's skyrocketing trajectory - marked by its recent 20 million user milestone and plans for US expansion - is underpinned by a relentless
[ 메디채널 황정호 기자 ] Recognition highlights DXC's market-leading technology, AI innovation, and industry expertise ASHBURN, Va., Oct. 14, 2025 -- DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services provider, has been named a Leader by global research firm Everest Group in its new report, "Property and Casualty (P&C) Insurance BPS PEAK Matrix® Assessment 2025." DXC was also awarded Star Performer status for demonstrating forward and upward movement from the previous edition of the report published in 2023. The Everest Group report h
New research highlights the Pictor PictVet™ Mycoplasma bovis IgG Multiplex ELISA's enhanced analytical performance through multiplexing and its potential to enhance global disease management. CARLSBAD, Calif., Oct. 14, 2025 -- Mycoplasma bovis is a devastating pathogen that threatens cattle health and productivity worldwide. In the United States alone, economic losses due to M. bovis mastitis are estimated to be above $100 million annually. While Mycoplasma bovis is not a human infection risk, it is a public health systems risk — through antimicrobial resistance, food security
NEW YORK, Oct. 14, 2025 -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content Advisory: Pre-Market Update + Etsy transfers stock listing to NYSE Kristen Scholer delivers the pre-market update on October 14th Equities are lower Tuesday morning after the S&P 500 booked its best daily rally since May, finishing Monday's session up 1.6%. Volatility has returned to the markets since Friday amid concerns of
BOSTON, Oct. 14, 2025 -- Complete Genomics, a leading innovator in genomic sequencing, today announced a series of milestones at the American Society of Human Genetics (ASHG) Annual Meeting, Oct. 14–18, 2025 in Boston. At ASHG 2025, for the first time, Complete Genomics will host a DNBSEQ™ User Group Meeting to bring together researchers and customers to share best practices, explore applications across oncology, rare disease and population genomics, and hear updates from the company on product innovations. The meeting will take place on Tuesday, Oct. 14, 2025, 8:30 a.m. - 5:00 p.m. ED
STAMFORD, Conn., Oct. 14, 2025 -- Sankaty Jet Capital, a new business aviation finance platform, today announced its official launch. Sankaty Jet Capital, a business aviation lending platform, was formed to provide financing solutions for counterparties across the business aviation industry. Ford von Weise, who will serve as Chief Executive Officer (CEO) of Sankaty Jet Capital, has over 25 years of experience in the business aviation finance industry. Prior to founding Sankaty Jet Capital, Mr. von Weise was Director and Head of Aircraft Finance & Advisory Services at Citi P
CHENNAI, India, Oct. 14, 2025 -- Indian Institute of Technology Madras (IIT Madras), India's No:1 Ranked Educational Institution, is partnering with Hyundai Motor India Foundation (HMIF), the CSR arm of Hyundai Motor India Limited (HMIL), to launch 'Hyundai Hope for Cancer' - a pioneering initiative dedicated to transforming paediatric cancer care in India. As part of its multi-year commitment towards this cause, HMIF has allocated a social impact investment of INR 56 Crore towards this landmark project. HMIL is the Indian arm of the South Korean automaker Hyundai Motor
CHENNAI, India, Oct. 14, 2025 -- Indian Institute of Technology Madras (IIT Madras), India's No:1 Ranked Educational Institution, is partnering with Hyundai Motor India Foundation (HMIF), the CSR arm of Hyundai Motor India Limited (HMIL), to launch 'Hyundai Hope for Cancer' - a pioneering initiative dedicated to transforming paediatric cancer care in India. As part of its multi-year commitment towards this cause, HMIF has allocated a social impact investment of INR 56 Crore towards this landmark project. HMIL is the Indian arm of the South Korean automaker Hyundai Motor
[ 메디채널 김갑성 기자 ] —— Globally Pioneering POGMENT Triple-Helix Biomimetic Collagen Debuts at Chinese Biomaterials Congress 2025 CHENGDU, China, Oct. 14, 2025 -- The 2025 Chinese Biomaterials Congress recently convened in Shaoxing, Zhejiang, bringing together a prestigious gathering of leading minds in the field. Attendees included Chinese Academy of Engineering academicians Zhang Xingdong and Wang Yingjun, Chinese Academy of Sciences academicians Chen Xuesi, Tang Peifu, and Chen Chunying, alongside renowned international experts such as U.S. National Academy of Engineering member Leonar